GREGORY SINCLAIR CONNOR, M.D.
Neurology at Yale Ave, Tulsa, OK
License number
Oklahoma 18269
Category
Neurology
Type
Neurology
Address
Address
6585 S Yale Ave STE. 620, Tulsa, OK 74136
Phone
(918) 481-4781
(918) 481-4796 (Fax)
(918) 481-4796 (Fax)
Personal information
See more information about GREGORY SINCLAIR CONNOR at radaris.comName
Address
Phone
4118 62Nd St, Tulsa, OK 74136
5613 5Th St, Tulsa, OK 74127
6585 Yale, Yale, OK 74136
6585 Yale Ave, Tulsa, OK 74136
8626 Fulton Ave, Tulsa, OK 74137
Professional information
Gregory Sinclair Connor, Tulsa OK
Specialties:
Neurologist
Address:
6585 S Yale Ave, Tulsa, OK 74136
Education:
University of Oklahoma, College of Medicine - Doctor of Medicine
The Mayo Clinic - Residency - Neurology
The Mayo Clinic - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Dr. Gregory S Connor, Tulsa OK - MD (Doctor of Medicine)
Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
Neurological Center Of Oklahoma
6585 S Yale Ave SUITE 620, Tulsa 74136
(918) 481-4781 (Phone)
6585 S Yale Ave SUITE 620, Tulsa 74136
(918) 481-4781 (Phone)
Certifications:
Neurology, 1991
Languages:
English
Education:
Medical School
University of Oklahoma / Health Sciences Center
Graduated: 1984
George Washington University
Mayo Clinic-Rochester
University of Oklahoma / Health Sciences Center
Graduated: 1984
George Washington University
Mayo Clinic-Rochester
Background:
Sanction: 1 time(s)
Gregory S Connor, Tulsa OK
Specialties:
Neurology, Internal Medicine
Work:
Neurological Center of Oklahoma Inc.
6585 S Yale Ave, Tulsa, OK 74136
6585 S Yale Ave, Tulsa, OK 74136
Education:
University of Oklahoma(1984)
Combination Therapy Comprising Anti-Diabetic And Anticonvulsant Agents
US Patent:
6686337, Feb 3, 2004
Filed:
Oct 25, 2001
Appl. No.:
10/042425
Inventors:
Gregory S. Connor - Tulsa OK
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A01N 4304
US Classification:
514 23, 514454, 514601
Abstract:
Combination therapy comprising anti-diabetic agents and anticonvulsant derivatives useful for the treatment of Type II diabetes mellitus and Syndrome X are disclosed.
Combination Therapy Comprising Anti-Diabetic And Anticonvulsant Agents
US Patent:
2004015, Aug 12, 2004
Filed:
Jan 23, 2004
Appl. No.:
10/764424
Inventors:
Gregory Connor - Tulsa OK, US
International Classification:
A61K031/70, A61K031/255
US Classification:
514/023000, 514/453000, 514/517000
Abstract:
Combination therapy comprising anti-diabetic agents and anticonvulsant derivatives useful for the treatment of Type II diabetes mellitus and Syndrome X are disclosed.
Anticonvulsant Derivatives Useful In Treating Essential Tremor
US Patent:
6214867, Apr 10, 2001
Filed:
Feb 15, 2000
Appl. No.:
9/504151
Inventors:
Gregory S. Connor - Tulsa OK
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 3135
US Classification:
514455
Abstract:
Anticonvulsant derivatives useful in treating essential tremor are disclosed.